# Amarin Corporation plc (AMRN)

> Source: Nexqual · https://nexqual.com/AMRN · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Amarin Corporation plc (AMRN), nexqual.com/AMRN" · informational, not investment advice.

**Price:** USD 11.57 (-0.34% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 11.61 · day 11.56–11.85 · 52w 11.34–20.9 · market cap $244M · NCM

## Key facts
- Analysts: Strong Sell (mean 4.50 on a 1–5 scale) (2 analysts), mean target USD 12.5 (range 12–13).
- Total return with dividends: 1Y -42.4% vs S&P 500 +18.1%; 5Y -88.8% vs S&P 500 +85.1%.
- Next earnings: 2026-10-28, EPS estimate USD -0.02, revenue estimate $43.7M.

## Analysts
Consensus Strong Sell (mean 4.50 on a 1–5 scale), 2 analysts; mean target USD 12.5 (low 12, high 13).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -42.4% | -88.8% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -42.5% | -35.4% |
| Volatility (annualized) | 41.6% | 69.5% |
| Max drawdown | -43.1% (Oct 2025→Oct 2026) | -92.3% (Oct 2021→Mar 2025) |

## Peers (Drug Manufacturers - General)
OGN (Organon & Co.) USD 13.76 -0.07% · GRFS (Grifols, S.A.) USD 7.54 +5.16% · BIIB (Biogen Inc.) USD 235.35 +2.82% · SNY (Sanofi) USD 40.29 +2.99% · GSK (GSK plc) USD 49.02 +5.94% · BMY (Bristol-Myers Squibb Company) USD 60.57 +6.88%

## More
Full page: https://nexqual.com/AMRN · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt